![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
JSTL Pharma LLP is embarking on a groundbreaking venture, aiming to establish a state-of-the-art bulk pharmaceuticals and intermediates facility in Kadechur, Kalaburagi, Karnataka. With a projected investment of 17 Crores, this initiative signifies the company's commitment to advancing pharmaceutical manufacturing in India. The facility is designed to have a capacity of 81.73 tonnes per month for bulk pharmaceuticals and intermediates, alongside 60 kiloliters per day for treated effluents.
The estimated project cost stands at approximately 17 billion rupees, reflecting the scale and ambition of JSTL Pharma LLP's endeavor. With an annual production capacity of 100 tonnes, the facility aims to cater to the increasing demand for bulk drugs and intermediates in the pharmaceutical industry.
JSTL Pharma LLP is a leading producer of bulk pharmaceuticals and intermediates in India, with existing facilities in Karnataka and Telangana. The new project in Kadechur forms a strategic part of the company's expansion strategy, aimed at meeting growing market demands and solidifying its position in the industry.
The project is being financed through a combination of debt and equity, with debt financing arranged by a consortium of banks led by the State Bank of India. Equity financing is provided by the promoters of JSTL Pharma LLP, demonstrating their confidence in the project's success and long-term viability.
News by Rahul Yelligetti
